Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-025615

Options or other derivatives

  • Director acquired 0 shares (option exercise)
  • Director acquired 56,639 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-07-24 Exercise or conversion : show line 1 in the form 8% Unsecured Convertible Promissory Note −0 D
2023-07-24 Exercise or conversion : show line 2 in the form Series D-1 Convertible Preferred Stock +56,639 535,565 D
Loading xslF345X05/ownership.xml…